Porton Pharma Solutions Ltd. (300363.SZ)
CNY 14.35
(-2.38%)
CNY 14.35
(-2.38%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 1.07 Billion CNY | 105.74% |
| 2022 | 520.24 Million CNY | 124.89% |
| 2021 | 231.33 Million CNY | 116.17% |
| 2020 | 107.01 Million CNY | -55.73% |
| 2019 | 241.74 Million CNY | -5.34% |
| 2018 | 255.36 Million CNY | -39.52% |
| 2017 | 422.22 Million CNY | 130.01% |
| 2016 | 183.56 Million CNY | -40.75% |
| 2015 | 309.83 Million CNY | 231.93% |
| 2014 | 93.34 Million CNY | 182.45% |
| 2013 | 33.04 Million CNY | -57.63% |
| 2012 | 77.99 Million CNY | 35.86% |
| 2011 | 57.4 Million CNY | 8.35% |
| 2010 | 52.98 Million CNY | 142.48% |
| 2009 | 21.85 Million CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 1.07 Billion CNY | 1.65% |
| 2024 Q1 | 1.05 Billion CNY | -1.13% |
| 2024 Q3 | 1.07 Billion CNY | -0.32% |
| 2023 Q4 | 1.07 Billion CNY | -4.88% |
| 2023 FY | 1.07 Billion CNY | 105.74% |
| 2023 Q3 | 1.12 Billion CNY | 7.84% |
| 2023 Q2 | 1.04 Billion CNY | 35.44% |
| 2023 Q1 | 770.42 Million CNY | 48.09% |
| 2022 Q2 | 883.56 Million CNY | 29.59% |
| 2022 Q1 | 681.81 Million CNY | 194.73% |
| 2022 FY | 520.24 Million CNY | 124.89% |
| 2022 Q4 | 520.24 Million CNY | -6.65% |
| 2022 Q3 | 557.33 Million CNY | -36.92% |
| 2021 Q3 | 143.9 Million CNY | -18.26% |
| 2021 Q1 | 167.21 Million CNY | 56.25% |
| 2021 FY | 231.33 Million CNY | 116.17% |
| 2021 Q4 | 231.33 Million CNY | 60.75% |
| 2021 Q2 | 176.05 Million CNY | 5.29% |
| 2020 Q2 | 278.85 Million CNY | -1.34% |
| 2020 FY | 107.01 Million CNY | -55.73% |
| 2020 Q4 | 107.01 Million CNY | -63.68% |
| 2020 Q3 | 294.65 Million CNY | 5.67% |
| 2020 Q1 | 282.64 Million CNY | 16.92% |
| 2019 Q1 | 185.36 Million CNY | -27.41% |
| 2019 Q3 | 159.26 Million CNY | -6.39% |
| 2019 FY | 241.74 Million CNY | -5.34% |
| 2019 Q4 | 241.74 Million CNY | 51.79% |
| 2019 Q2 | 170.12 Million CNY | -8.22% |
| 2018 Q4 | 255.36 Million CNY | -43.66% |
| 2018 Q3 | 453.29 Million CNY | -4.15% |
| 2018 Q2 | 472.92 Million CNY | -7.09% |
| 2018 Q1 | 509 Million CNY | 20.55% |
| 2018 FY | 255.36 Million CNY | -39.52% |
| 2017 Q2 | 321.89 Million CNY | -1.17% |
| 2017 Q1 | 325.71 Million CNY | 77.44% |
| 2017 FY | 422.22 Million CNY | 130.01% |
| 2017 Q4 | 422.22 Million CNY | 33.44% |
| 2017 Q3 | 316.41 Million CNY | -1.7% |
| 2016 Q1 | 301.85 Million CNY | -2.58% |
| 2016 Q2 | 240.97 Million CNY | -20.17% |
| 2016 Q3 | 221.27 Million CNY | -8.18% |
| 2016 FY | 183.56 Million CNY | -40.75% |
| 2016 Q4 | 183.56 Million CNY | -17.04% |
| 2015 FY | 309.83 Million CNY | 231.93% |
| 2015 Q4 | 309.83 Million CNY | 2.45% |
| 2015 Q3 | 302.42 Million CNY | 47.71% |
| 2015 Q2 | 204.74 Million CNY | 54.27% |
| 2015 Q1 | 132.71 Million CNY | 42.18% |
| 2014 Q4 | 93.34 Million CNY | 56.88% |
| 2014 Q3 | 59.5 Million CNY | 0.0% |
| 2014 FY | 93.34 Million CNY | 182.45% |
| 2014 Q2 | 59.5 Million CNY | -17.06% |
| 2014 Q1 | 71.74 Million CNY | 117.08% |
| 2013 FY | 33.04 Million CNY | -57.63% |
| 2013 Q4 | 33.04 Million CNY | 0.0% |
| 2013 Q2 | 45.38 Million CNY | 0.0% |
| 2013 Q1 | - CNY | 0.0% |
| 2012 FY | 77.99 Million CNY | 35.86% |
| 2011 FY | 57.4 Million CNY | 8.35% |
| 2010 FY | 52.98 Million CNY | 142.48% |
| 2009 FY | 21.85 Million CNY | 0.0% |